Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chrubasik J., Wüst H., Friedrich G., Geller E. Absorption and bioavailability of nebulized morphine. Br J Anaesth. 1988 Aug;61(2):228–230. doi: 10.1093/bja/61.2.228. [DOI] [PubMed] [Google Scholar]
- De Conno F., Ripamonti C., Saita L., MacEachern T., Hanson J., Bruera E. Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain. J Clin Oncol. 1995 Apr;13(4):1004–1008. doi: 10.1200/JCO.1995.13.4.1004. [DOI] [PubMed] [Google Scholar]
- Dover S. B. Syringe driver in terminal care. Br Med J (Clin Res Ed) 1987 Feb 28;294(6571):553–555. doi: 10.1136/bmj.294.6571.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finn J. W., Walsh T. D., MacDonald N., Bruera E., Krebs L. U., Shepard K. V. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer. J Clin Oncol. 1993 May;11(5):967–972. doi: 10.1200/JCO.1993.11.5.967. [DOI] [PubMed] [Google Scholar]
- Hanks G. W. Antiemetics for terminal cancer patients. Lancet. 1982 Jun 19;1(8286):1410–1410. doi: 10.1016/s0140-6736(82)92522-3. [DOI] [PubMed] [Google Scholar]
- Hanks G. W. Controlled-release morphine (MST Contin) in advanced cancer. The European experience. Cancer. 1989 Jun 1;63(11 Suppl):2378–2382. doi: 10.1002/1097-0142(19890601)63:11<2378::aid-cncr2820631150>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Hanks G. W., Hoskin P. J., Aherne G. W., Turner P., Poulain P. Explanation for potency of repeated oral doses of morphine? Lancet. 1987 Sep 26;2(8561):723–725. doi: 10.1016/s0140-6736(87)91083-x. [DOI] [PubMed] [Google Scholar]
- Hogan Q., Haddox J. D., Abram S., Weissman D., Taylor M. L., Janjan N. Epidural opiates and local anesthetics for the management of cancer pain. Pain. 1991 Sep;46(3):271–279. doi: 10.1016/0304-3959(91)90110-J. [DOI] [PubMed] [Google Scholar]
- Kaiko R. F. The therapeutic equivalence of i.m. and p.o. administration of morphine--1:3 or 1:6? J Palliat Care. 1988 May;4(1-2):64–66. [PubMed] [Google Scholar]
- Kalso E., Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther. 1990 May;47(5):639–646. doi: 10.1038/clpt.1990.85. [DOI] [PubMed] [Google Scholar]
- Leslie S. T., Rhodes A., Black F. M. Controlled release morphine sulphate tablets--a study in normal volunteers. Br J Clin Pharmacol. 1980 May;9(5):531–534. doi: 10.1111/j.1365-2125.1980.tb05858.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McQuay H. J., Moore R. A., Hand C. W., Sear J. W. Potency of oral morphine. Lancet. 1987 Dec 19;2(8573):1458–1459. doi: 10.1016/s0140-6736(87)91153-6. [DOI] [PubMed] [Google Scholar]
- McQuay H. J. The logic of alternative routes. J Pain Symptom Manage. 1990 Apr;5(2):75–77. doi: 10.1016/s0885-3924(05)80019-3. [DOI] [PubMed] [Google Scholar]
- Plummer J. L., Cherry D. A., Cousins M. J., Gourlay G. K., Onley M. M., Evans K. H. Long-term spinal administration of morphine in cancer and non-cancer pain: a retrospective study. Pain. 1991 Mar;44(3):215–220. doi: 10.1016/0304-3959(91)90088-F. [DOI] [PubMed] [Google Scholar]
- Portenoy R. K., Coyle N. Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Symptom Manage. 1990 Oct;5(5):307–319. doi: 10.1016/0885-3924(90)90047-n. [DOI] [PubMed] [Google Scholar]
- Poulain P., Hoskin P. J., Hanks G. W., A-Omar O., Walker V. A., Johnston A., Turner P., Aherne G. W. Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients. Br J Anaesth. 1988 Nov;61(5):569–574. doi: 10.1093/bja/61.5.569. [DOI] [PubMed] [Google Scholar]
- Ripamonti C., Bruera E. Rectal, buccal, and sublingual narcotics for the management of cancer pain. J Palliat Care. 1991 Spring;7(1):30–35. [PubMed] [Google Scholar]
- Schug S. A., Zech D., Grond S., Jung H., Meuser T., Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage. 1992 Jul;7(5):259–266. doi: 10.1016/0885-3924(92)90059-q. [DOI] [PubMed] [Google Scholar]
- Sjöberg M., Appelgren L., Einarsson S., Hultman E., Linder L. E., Nitescu P., Curelaru I. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand. 1991 Jan;35(1):30–43. doi: 10.1111/j.1399-6576.1991.tb03237.x. [DOI] [PubMed] [Google Scholar]
- Säwe J., Dahlström B., Rane A. Steady-state kinetics and analgesic effect of oral morphine in cancer patients. Eur J Clin Pharmacol. 1983;24(4):537–542. doi: 10.1007/BF00609900. [DOI] [PubMed] [Google Scholar]
- Säwe J. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986 Mar-Apr;11(2):87–106. doi: 10.2165/00003088-198611020-00001. [DOI] [PubMed] [Google Scholar]
- Twycross R. G. Control of pain. J R Coll Physicians Lond. 1984 Jan;18(1):32–39. [PMC free article] [PubMed] [Google Scholar]
- Twycross R. G. Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv. 1988;7(1):29–53. [PubMed] [Google Scholar]
- Twycross R. G. The therapeutic equivalence of oral and subcutaneous/intramuscular morphine sulphate in cancer patients. J Palliat Care. 1988 May;4(1-2):67–68. [PubMed] [Google Scholar]
- Vainio A., Ollila J., Matikainen E., Rosenberg P., Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995 Sep 9;346(8976):667–670. doi: 10.1016/s0140-6736(95)92281-4. [DOI] [PubMed] [Google Scholar]
- Zech D. F., Grond S. U., Lynch J., Dauer H. G., Stollenwerk B., Lehmann K. A. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients. Pain. 1992 Sep;50(3):293–301. doi: 10.1016/0304-3959(92)90034-9. [DOI] [PubMed] [Google Scholar]
- Zech D. F., Grond S., Lynch J., Hertel D., Lehmann K. A. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995 Oct;63(1):65–76. doi: 10.1016/0304-3959(95)00017-M. [DOI] [PubMed] [Google Scholar]